2024-12-29 22:26:11,562 - __main__ - INFO - Query submitted: Which papers are discussing irregular multivariate time series?

2024-12-29 22:26:11,562 - __main__ - INFO - Query submitted: Which papers are discussing irregular multivariate time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,464 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:37,465 - __main__ - INFO - Processing query with mode: local
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:27:49,389 - __main__ - INFO - Query completed in Local mode
2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:29:55,617 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:24,196 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,288 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:28,292 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:30,613 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,639 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series? and which models 

2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:30:49,642 - __main__ - INFO - Processing query with mode: global
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:31:08,837 - __main__ - INFO - Query completed in Global mode
2024-12-29 22:33:11,289 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:33:11,289 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:33:11,289 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:33:11,289 - __main__ - INFO - Query submitted: Which papers are discussing blood samples and time series?

2024-12-29 22:33:11,290 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:33:11,290 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:33:11,290 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:33:11,290 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:33:11,293 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 22:33:11,293 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 22:33:11,293 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 22:33:11,293 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 22:34:03,575 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 22:34:03,575 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 22:34:03,575 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 22:34:03,575 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 22:34:03,575 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 22:34:03,576 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:34:03,576 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:34:03,576 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:34:03,576 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:34:03,576 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 22:34:19,267 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 22:34:19,267 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 22:34:19,267 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 22:34:19,267 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 22:34:19,267 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:11:02,145 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:11:02,145 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:11:02,145 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:11:02,145 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:11:02,146 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:11:02,146 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:11:02,146 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:11:02,146 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:11:02,147 - __main__ - ERROR - Error processing query: QueryParam.__init__() got an unexpected keyword argument 'need_context'
2024-12-29 23:11:02,147 - __main__ - ERROR - Error processing query: QueryParam.__init__() got an unexpected keyword argument 'need_context'
2024-12-29 23:11:02,147 - __main__ - ERROR - Error processing query: QueryParam.__init__() got an unexpected keyword argument 'need_context'
2024-12-29 23:11:02,147 - __main__ - ERROR - Error processing query: QueryParam.__init__() got an unexpected keyword argument 'need_context'
2024-12-29 23:32:04,138 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:32:04,138 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:32:04,138 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:32:04,138 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:32:04,140 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:32:04,140 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:32:04,140 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:32:04,140 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:32:26,351 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:32:26,351 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:32:26,351 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:32:26,351 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:48:52,288 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:48:52,288 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:48:52,288 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:48:52,288 - __main__ - INFO - Query submitted: Which papers discuss methodological approaches for handling irregularly spaced time series data, specifically regarding missing blood sample measurements, and what are the mathematical frameworks for addressing such gaps in temporal data?
2024-12-29 23:48:52,289 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:48:52,289 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:48:52,289 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:48:52,289 - __main__ - INFO - Processing query with mode: hybrid
2024-12-29 23:48:52,292 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:48:52,292 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:48:52,292 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:48:52,292 - __main__ - INFO - Query completed in Hybrid mode
2024-12-29 23:52:55,245 - __main__ - INFO - Query submitted: Which papers are discussing irregular multivariate time series?

2024-12-29 23:52:55,245 - __main__ - INFO - Query submitted: Which papers are discussing irregular multivariate time series?

2024-12-29 23:52:55,245 - __main__ - INFO - Query submitted: Which papers are discussing irregular multivariate time series?

2024-12-29 23:52:55,245 - __main__ - INFO - Query submitted: Which papers are discussing irregular multivariate time series?

2024-12-29 23:52:55,245 - __main__ - INFO - Query submitted: Which papers are discussing irregular multivariate time series?

2024-12-29 23:52:55,246 - __main__ - INFO - Processing query with mode: mix
2024-12-29 23:52:55,246 - __main__ - INFO - Processing query with mode: mix
2024-12-29 23:52:55,246 - __main__ - INFO - Processing query with mode: mix
2024-12-29 23:52:55,246 - __main__ - INFO - Processing query with mode: mix
2024-12-29 23:52:55,246 - __main__ - INFO - Processing query with mode: mix
2024-12-29 23:53:05,821 - __main__ - INFO - Query completed in mix mode
2024-12-29 23:53:05,821 - __main__ - INFO - Query completed in mix mode
2024-12-29 23:53:05,821 - __main__ - INFO - Query completed in mix mode
2024-12-29 23:53:05,821 - __main__ - INFO - Query completed in mix mode
2024-12-29 23:53:05,821 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,480 - __main__ - INFO - Query submitted: what can you tell me about 6mp
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:21,482 - __main__ - INFO - Processing query with mode: hybrid
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:17:40,193 - __main__ - INFO - Query completed in hybrid mode
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,887 - __main__ - INFO - Query submitted: can we in some way use the 6mp dosage information in a timeseries forecasting ? 
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:40,889 - __main__ - INFO - Processing query with mode: mix
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:20:54,610 - __main__ - INFO - Query completed in mix mode
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,460 - __main__ - INFO - Chat input received: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:15,461 - __main__ - INFO - Prepared query: Previous conversation:

Current query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,446 - __main__ - INFO - Query result: {'response': "\n### Query\nPrevious conversation:\n\nCurrent query: can you further explain Utilizing 6MP Dosage Information in Time Series Forecasting\n\n### Response\nUtilizing 6MP (6-mercaptopurine) dosage information in time series forecasting involves examining how variations in the administration of this chemotherapy drug impact treatment outcomes, particularly for pediatric patients with Acute Lymphoblastic Leukemia (ALL). This analysis is pivotal as treatment personalization can significantly affect patient safety and drug efficacy.\n\n### Overview of 6MP and Its Role in Treatment\n\n6MP is a critical medication used in the maintenance therapy of childhood ALL. Its pharmacokinetics can vary widely among individuals due to genetic factors, such as the TPMT (Thiopurine Methyltransferase) genotype, which influences how patients metabolize the drug. The medication is often administered in a standardized dose, but adjustments may be made based on individual patient response, side effects, and the goal of achieving optimal therapeutic levels.\n\n### Time Series Analysis in 6MP Dosage\n\nIncorporating 6MP dosage into time series forecasting entails tracking patient responses over time relative to the administered doses. Various models such as the pharmacokinetic-pharmacodynamic (PKPD) models can be employed to predict treatment outcomes based on dosages administered at different intervals. The primary focus is on how the concentration of 6MP and its metabolites in the body affects clinical outcomes, such as levels of Absolute Neutrophil Count (ANC) and minimal residual disease (MRD) rates, all of which are crucial in monitoring treatment efficacy.\n\n### Data Sources and Methodology\n\nThe data used for this forecasting can be derived from various sources, including clinical trials like the ALL-92 study, which outlines treatment regimens that involve 6MP, and patient cohorts that document dosages and corresponding blood parameters. Implementing advanced data handling models like GRU-D (Gated Recurrent Unit with Decay) can assist in effectively managing missing values and irregular time intervals often inherent in clinical data. \n\n1. **Modeling with GRU-D**: This model can be particularly beneficial as it incorporates decay mechanisms that can capture the temporal dynamics of dosages and their effects on patient responses over time. By applying trainable decays to both input and hidden state transitions, GRU-D efficiently handles variations in patient data due to missed doses or irregular monitoring times.\n\n2. **Predictive Outcomes**: The performance of the GRU-D model can be evaluated based on its ability to predict the length of hospital stays or the likelihood of adverse effects associated with 6MP administration. Using metrics such as Mean Square Error (MSE) and Mean Absolute Error (MAE) allows researchers to assess the model's accuracy and refine treatment protocols.\n\n### Clinical Relevance\n\nUltimately, the integration of 6MP dosage information into time series forecasting models can enhance clinical decision-making, allowing healthcare providers to tailor treatment plans to individual patient needs. This approach aims to optimize therapeutic responses while minimizing the risks of toxicity, particularly by adjusting dosages based on ongoing monitoring of hematological parameters like ANC.\n\nIn conclusion, utilizing 6MP dosage information through time series forecasting facilitates a deeper understanding of treatment dynamics in pediatric oncology, promoting personalized medicine that can significantly improve patient outcomes in the context of leukemia treatments.\n\n### Search Mode\nhybrid\n", 'mode': 'hybrid', 'sources': [], 'time': '2025-01-02T17:24:28.446611', 'token_usage': None}
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 17:24:28,452 - __main__ - INFO - Response added to chat history
2025-01-02 18:06:54,084 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:06:54,084 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:07:08,808 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:07:08,808 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:07:08,808 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:07:08,808 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:08:16,666 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:08:16,666 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:08:16,666 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:08:16,666 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 448, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 122, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:10:57,696 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:10:57,696 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:10:57,696 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:10:57,696 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:10:57,696 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:10:57,696 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:10:57,696 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:10:57,696 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:11:51,920 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:11:51,920 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:11:51,920 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:11:51,920 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:11:51,920 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:11:51,920 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 442, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:13:30,077 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 445, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:13:30,077 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 445, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:13:30,077 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 445, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:13:30,077 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 445, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:13:30,077 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 445, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:13:30,077 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 445, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:13:30,077 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 445, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:13:30,077 - __main__ - ERROR - Configuration error: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 445, in <module>
    st.session_state["rag_manager"] = LightRAGManager(
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 61, in __init__
    self.rag = LightRAG(
TypeError: LightRAG.__init__() got an unexpected keyword argument 'openai_api_key'
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:31,103 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:37,490 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:15:39,061 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 105, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:16:58,078 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
2025-01-02 18:17:05,408 - __main__ - ERROR - Configuration error: No valid documents found to load
Traceback (most recent call last):
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/pages/Search.py", line 456, in <module>
    st.session_state["rag_manager"].load_documents()
  File "/Users/jesper/Projects/Dev_projects/KG_and_RAGs/Lightrag_test_app/src/lightrag_init.py", line 104, in load_documents
    raise Exception("No valid documents found to load")
Exception: No valid documents found to load
